Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Clinicians-related determinants of anticoagulation therapy and prophylaxis in Nigeria.

Anakwue R, Nwagha T, Ukpabi OJ, Obeka N, Onwubuya E, Onwuchekwa U, Azubuike B, Okoye I.

Ann Afr Med. 2017 Oct-Dec;16(4):164-169. doi: 10.4103/aam.aam_35_17.

2.

Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review.

Meinshausen M, Rieckert A, Renom-Guiteras A, Kröger M, Sommerauer C, Kunnamo I, Martinez YV, Esmail A, Sönnichsen A.

BMC Geriatr. 2017 Oct 16;17(Suppl 1):225. doi: 10.1186/s12877-017-0572-7. Review.

3.

Secondary prevention treatment after acute stroke in older South Asian, Chinese and other Canadians: a retrospective data analysis.

Khan NA, McAlister FA, Pilote L, Palepu A, Quan H, Hill MD, Fang J, Kapral MK.

CMAJ Open. 2017 Sep 11;5(3):E702-E709. doi: 10.9778/cmajo.20160147.

4.

Smoking cessation and outcome after ischemic stroke or TIA.

Epstein KA, Viscoli CM, Spence JD, Young LH, Inzucchi SE, Gorman M, Gerstenhaber B, Guarino PD, Dixit A, Furie KL, Kernan WN; IRIS Trial Investigators.

Neurology. 2017 Oct 17;89(16):1723-1729. doi: 10.1212/WNL.0000000000004524. Epub 2017 Sep 8.

PMID:
28887378
5.

Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack.

Edwards JD, Kapral MK, Fang J, Swartz RH.

CMAJ. 2017 Jul 24;189(29):E954-E961. doi: 10.1503/cmaj.161142.

6.

Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic Attack.

Bath PM, May J, Flaherty K, Woodhouse LJ, Dovlatova N, Fox SC, England TJ, Krishnan K, Robinson TG, Sprigg N, Heptinstall S, Investigators T.

Stroke Res Treat. 2017;2017:7365684. doi: 10.1155/2017/7365684. Epub 2017 May 24.

7.

Preventative Measures of Stroke in Patients With Atrial Fibrillation.

Adlan A, Yh Lip G.

J Atr Fibrillation. 2012 Apr 14;4(6):399. doi: 10.4022/jafib.399. eCollection 2012 Apr-May. Review.

8.

Stroke Prevention in Atrial Fibrillation.

Katsnelson M, Koch S, Rundek T.

J Atr Fibrillation. 2010 Oct 22;3(3):279. doi: 10.4022/jafib.279. eCollection 2010 Oct-Nov. Review.

9.

Atrial Fibrillation: The New Epidemic of the Ageing World.

Aronow WS, Banach M.

J Atr Fibrillation. 2009 Apr 1;1(6):154. doi: 10.4022/jafib.154. eCollection 2009 Apr-May. Review.

10.

Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa).

Hatori Y, Sakai H, Kunishima T, Hatori N, Chen L, Ishigami T, Satoh N; ASSAF-K Investigators.

J Arrhythm. 2017 Apr;33(2):111-116. doi: 10.1016/j.joa.2016.07.008. Epub 2016 Aug 23.

11.

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries.

Ogawa H, Senoo K, An Y, Shantsila A, Shantsila E, Lane DA, Wolff A, Akao M, Lip GYH.

EBioMedicine. 2017 Apr;18:199-203. doi: 10.1016/j.ebiom.2017.03.022. Epub 2017 Mar 16.

12.

Cardiac diagnostic work-up for atrial fibrillation after transient ischaemic attacks in England and Wales: results from a cross-sectional survey.

Geraghty O, Korompoki E, Filippidis FT, Rudd A, Veltkamp R.

BMJ Open. 2016 Nov 10;6(11):e012714. doi: 10.1136/bmjopen-2016-012714.

13.

Magnetic Resonance Perfusion Imaging Provides a Significant Tool for the Identification of Cardioembolic Stroke.

Lin CH, Tsai YH, Lee JD, Weng HH, Yang JT, Lin LC, Lin YH, Wu CY, Huang YC, Hsu HL, Lee M, Hsu CY, Pan YT, Huang YC.

Curr Neurovasc Res. 2016;13(4):271-276.

14.

Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.

Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P.

Clin Pharmacol. 2016 Aug 11;8:93-107. doi: 10.2147/CPAA.S105165. eCollection 2016.

15.

Exploratory Network Meta Regression Analysis of Stroke Prevention in Atrial Fibrillation Fails to Identify Any Interactions with Treatment Effect.

Batson S, Sutton A, Abrams K.

PLoS One. 2016 Aug 25;11(8):e0161864. doi: 10.1371/journal.pone.0161864. eCollection 2016.

16.

Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL.

Freeman JV, Hutton DW, Barnes GD, Zhu RP, Owens DK, Garber AM, Go AS, Hlatky MA, Heidenreich PA, Wang PJ, Al-Ahmad A, Turakhia MP.

Circ Arrhythm Electrophysiol. 2016 Jun;9(6). pii: e003407. doi: 10.1161/CIRCEP.115.003407.

17.

How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices.

Bridge F, Thijs V.

J Stroke. 2016 May;18(2):121-8. doi: 10.5853/jos.2016.00150. Epub 2016 May 31. Review.

18.

Comparative Effectiveness of Interventions for Stroke Prevention in Atrial Fibrillation: A Network Meta-Analysis.

Tereshchenko LG, Henrikson CA, Cigarroa J, Steinberg JS.

J Am Heart Assoc. 2016 May 20;5(5). pii: e003206. doi: 10.1161/JAHA.116.003206.

19.

Stroke survivors', caregivers' and GPs' attitudes towards a polypill for the secondary prevention of stroke: a qualitative interview study.

Jamison J, Graffy J, Mullis R, Mant J, Sutton S.

BMJ Open. 2016 May 13;6(5):e010458. doi: 10.1136/bmjopen-2015-010458.

20.

Non-Vitamin K Oral Anticoagulants in Stroke Patients: Practical Issues.

Diener HC, Kleinschnitz C.

J Stroke. 2016 May;18(2):138-45. doi: 10.5853/jos.2016.00157. Epub 2016 May 10. Review.

Supplemental Content

Support Center